HOME >> BIOLOGY >> NEWS
Other highlights in the August 17 JNCI

Method of Breast Cancer Detection May Be Prognostic Factor

Whether breast cancer is detected during screening mammograms or detected in other ways may help define a woman's prognosis, according to a new study.

Screening mammography detects breast cancers at an earlier stage of development than breast cancers detected symptomatically--the so-called stage shift--and so mammographically detected breast cancers tend to have better prognoses. This stage shift is subject to various biases, so that earlier detection may not translate into lower mortality. In addition, screen-detected cancers tend to grow more slowly than cancers detected in other ways, which may also affect survival.

To examine the prognostic value of the method of breast cancer detection on survival, Donald A. Berry, Ph.D., of the University of Texas M. D. Anderson Cancer Center in Houston, and colleagues used data from three large North American randomized controlled trials of breast cancer screening. In all three trials, the authors found that after adjusting for tumor size, lymph node status, and disease stage, clinically detected cancers were associated with a 53% greater hazard of death from breast cancer compared with screen-detected cancers.

In an editorial, Ian F. Tannock, M.D., Ph.D., and Monika K. Krzyzanowska, M.D., of Princess Margaret Hospital in Toronto, discuss these results and those of another recent study, both of which reported better survival associated with screen-detected cancers. They conclude, however, that knowing the method of detection might add only limited prognostic value beyond that of well-established prognostic factors.

Contacts:

  • Article: Laura Sussman, Communications Office, M. D. Anderson Cancer Center, 713-745-2457, lsussman@mdanderson.org
  • Editorial: Jennifer Kohm, Princess Margaret Hospital, 416-946-2846, jennifer.kohm@uhn
    '"/>


  • Contact: Sarah L. Zielinski
    jncimedia@oupjournals.org
    301-841-1287
    Journal of the National Cancer Institute
    16-Aug-2005


    Page: 1 2 3 4 5

    Related biology news :

    1. Other highlights in the Aug. 7 JNCI
    2. Other highlights in the July 24 JNCI
    3. Other highlights from the July 10 JNCI
    4. Other highlights in JNCI, June 26
    5. Other highlights in JNCI, June 12
    6. Other highlights from the June 6 JNCI
    7. Other highlights in the May 16 JNCI
    8. Other highlights from the April 18 Journal of the National Cancer Institute
    9. Other highlights from the March 21 JNCI
    10. Other highlights in the March 7 JNCI
    11. Other highlights in the Feb. 21 JNCI

    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:7/10/2020)... ... ... Today CJ BIO announced the first in a series of Food Ingredient ... that is revolutionizing ingredient mixes, nutritional content and flavor profiles across a range of ... 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition of the IFT Annual Meeting ...
    (Date:7/1/2020)... ... 01, 2020 , ... Cure Glioblastoma, a registered 501(c)(3) nonprofit ... aggressive adult brain cancer—announced today the appointments of its first Senior Fellows: John ... the organization’s initiatives and overall vision. , "Senior Fellows are more than advisors; ...
    (Date:6/23/2020)... ... June 23, 2020 , ... ... healthcare, and Renovagen Ltd, a UK supplier and manufacturer of innovative portable renewable ... testing operations in the fight against the COVID-19 pandemic in Zambia. , One ...
    Breaking Biology News(10 mins):
    (Date:9/1/2020)... ... September 01, 2020 , ... Slone Partners , a ... the placement of Julianne Averill , CPA, as Chief Financial Officer at ... and implementing key business strategies to accelerate Alveo’s growth as the company advances ...
    (Date:8/15/2020)... ... 13, 2020 , ... True Terpenes , the leading platform for terpene ... (SAB) to research the medical potential of terpenes and the potential entourage effect ... The board is focused on expanding the recently launched line of effects-based terpenes - ...
    (Date:8/12/2020)... ... August 11, 2020 , ... The FSHD Society ... Muscular Dystrophy Clinical Trial Research Network (FSHD CTRN), with consideration of ... a consortium of academic research centers in the United States and Europe with ...
    (Date:8/12/2020)... ... August 12, 2020 , ... ... International), a global leader in FDA compliance consulting has been named on its ... companies. The list represents a unique look at the most successful companies within ...
    Breaking Biology Technology:
    Cached News: